WO2025224678 - SOLID STATE FORMS OF MILVEXIAN AND PROCESS FOR PREPARATION THEREOF

National phase entry is expected:
Publication Number WO/2025/224678
Publication Date 30.10.2025
International Application No. PCT/IB2025/054297
International Filing Date 24.04.2025
Title **
[English] SOLID STATE FORMS OF MILVEXIAN AND PROCESS FOR PREPARATION THEREOF
[French] FORMES À L'ÉTAT SOLIDE DE MILVEXIAN ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SOMASUNDARAM, Meenakshi Sundaram
SINGH, Chanchal
KAUSHIK, Babita
Priority Data
202411032896   25.04.2024   IN
202411069962   16.09.2024   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3204
EPO Filing, Examination, Granting22910
Japan Filing, Examination, Granting2958
South Korea Filing, Examination, Granting3739
USA Filing, Examination, Granting12540
MasterCard Visa
Total: 45,351
Contact Us
Abstract[English] The present disclosure relates to Milvexian solid state forms, in embodiments crystalline polymorphs of Milvexian, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.[French] La présente divulgation concerne des formes à l'état solide de Milvexian, dans des modes de réalisation, des polymorphes cristallins de Milvexian, des procédés de préparation associés, des compositions pharmaceutiques associées et des procédés d'utilisation associés.